関連する実験動画

Updated: Sep 9, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

複雑な炎症指数は,皮膚経冠動脈介入を受けた急性冠動脈症候群患者の予後リスクを予測する

Ge Song¹, Yan Liu¹, Ying Zhang^1,2

¹Department of Cardiology, The Affiliated Hospital of Chengde Medical University, Chengde, 067000, China.

|September 1, 2025

まとめ

特にコレステロール値と組み合わせた場合,急性冠動脈症候群 (ACS) の患者における重大な心血管疾患 (MACE) の有意な予測要因である. これらのマーカーは長期的な予後が悪いことを示します.

科学分野:

心臓病科
バイオマーカー
予測リスク評価

背景:

急性冠動脈症候群 (ACS) の患者の生存率を改善するために,正確な予後リスク評価は非常に重要です.
新しいバイオマーカーの調査は,ACS管理におけるリスクの階層化を高めることができます.

研究の目的:

主要な心血管疾患 (MACE) の予測における中性細胞対リンパ球対血小板比 (NLPR) と中性細胞対リンパ球比 (NLR) の予後的役割を評価する.
皮膚経冠動脈介入 (PCI) を受けているACS患者における高密度脂質タンパク質コレステロール (HDL-C) と低密度脂質タンパク質コレステロール (LDL-C) の併用予測値の評価.

主な方法:

PCIを受けた1,263人のACS患者の遡及分析 (2016年1月 - 2018年12月).
MACE (n=54) と非MACE (n=1, 209) に分類された患者.
心臓発作による死亡率,心不全による再入院,心筋梗塞,インステントの静止症として定義される.

主要な成果:

低NLPRとNLR患者の累積生存率は高かった.
NLPR/ HDL- C,NLPR×LDL- C,NLR/ HDL- C,NLR×LDL- Cの比率が上昇すると,累積生存率が著しく低下した.
NLPR,NLR,およびその組み合わせと脂質濃度に関する特定の値が独立した危険因子として特定されました.

結論:

NLPRとNLRは,特にHDL- CとLDL- Cレベルと組み合わせた場合,PCI後のACS患者における独立した予後リスク因子です.
これらの比率 (NLPR ≥2. 843,NLPR/HDL-C ≥1. 977,NLPR×LDL-C ≥4. 608,NLR ≥0. 025,NLR/HDL-C ≥0. 030,NLR×LDL-C ≥0. 038) は,長期的な予後のための貴重なマーカーとして機能する.
これらの発見は,ACS患者のリスクの階層化と治療戦略の改善に役立ちます.

キーワード:

急性冠動脈症候群中性細胞-リンパ球比中性細胞とリンパ球の比率経皮冠動脈介入予測

さらに関連する動画

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

関連する概念動画

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...